Tevogen Bio Holdings Inc.
General ticker "TVGN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $55.1M (TTM average)
Tevogen Bio Holdings Inc. does not follow the US Stock Market performance with the rate: -20.5%.
Estimated limits based on current volatility of 4.1%: low 6.46$, high 7.01$
Factors to consider:
- Total employees count: 18 (0.0%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Inability to raise capital, Failure to obtain approval, Commercialization delays, Manufacturing disruptions, Regulatory and compliance
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.07$, 28.34$]
- 2026-12-31 to 2027-12-31 estimated range: [3.30$, 15.65$]
Financial Metrics affecting the TVGN estimates:
- Negative: with PPE of -2.5 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Negative: negative Industry operating cash flow (median)
- Negative: negative Industry operating income (median)
- Negative: Shareholder equity ratio, % of -187.88 <= 7.04
- Negative: 0.07 < Interest expense per share per price, % of 0.32
Short-term TVGN quotes
Long-term TVGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $8.84MM | $53.56MM | $26.14MM |
| Operating Income | $-8.84MM | $-53.56MM | $-26.14MM |
| Non-Operating Income | $-51.63MM | $39.84MM | $-0.13MM |
| Interest Expense | $0.26MM | $0.18MM | $0.20MM |
| R&D Expense | $4.40MM | $31.03MM | $11.11MM |
| Income(Loss) | $-60.48MM | $-13.73MM | $-26.28MM |
| Net Income(Loss)* | $-60.48MM | $-13.73MM | $-26.28MM |
| Stockholders Equity | $-94.43MM | $-6.67MM | $-8.23MM |
| Assets | $5.51MM | $3.46MM | $4.38MM |
| Operating Cash Flow | $-8.17MM | $-12.00MM | $-12.33MM |
| Capital expenditure | $0.13MM | $0.00MM | $0.06MM |
| Investing Cash Flow | $-0.13MM | $0.00MM | $-0.06MM |
| Financing Cash Flow | $3.87MM | $12.23MM | $11.66MM |
| Earnings Per Share** | $-18.28 | $-4.68 | $-7.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.